BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15258046)

  • 1. New treatments for colon cancer.
    Slevin M; Payne S
    BMJ; 2004 Jul; 329(7458):124-6. PubMed ID: 15258046
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
    Cassidy J
    Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
    [No Abstract]   [Full Text] [Related]  

  • 3. NCCN guideline updates: colon and rectal cancers, version 1.2004.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
    [No Abstract]   [Full Text] [Related]  

  • 4. Accrual delayed in adjuvant bevacizumab trial.
    Tuma RS
    J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant therapy for colon cancer].
    Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
    Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 8. Current stages of adjuvant treatment of colon cancer.
    Köhne CH
    Ann Oncol; 2012 Sep; 23 Suppl 10():x71-6. PubMed ID: 22987996
    [No Abstract]   [Full Text] [Related]  

  • 9. [Successes in late solid tumors. New therapy offer].
    Arnheim K
    MMW Fortschr Med; 2004 Nov; 146(47):71. PubMed ID: 15624667
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of colonic cancer].
    Block S
    Soins; 2010 Mar; (743):46. PubMed ID: 20423037
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.
    Robertson JD; Botwood NA; Rothenberg ML; Schmoll HJ
    Clin Colorectal Cancer; 2009 Jan; 8(1):59-60. PubMed ID: 19203899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted agents for adjuvant therapy of colon cancer.
    Saif MW
    Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in adjuvant chemotherapy for colon cancer.
    Nelson H
    Minerva Chir; 1992 Mar; 47(5):213-22. PubMed ID: 1594115
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.
    Beaven AW; Goldberg RM
    Oncology (Williston Park); 2006 Apr; 20(5):461-9; discussion 469-70, 473-5. PubMed ID: 16739745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
    Malik Z; Eng C
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
    [No Abstract]   [Full Text] [Related]  

  • 16. Overstated conclusions of a pooled analysis of bevacizumab in colon cancer.
    Goffin JR; Talavera JR
    J Clin Oncol; 2006 Jan; 24(3):528-9; author reply 529-30. PubMed ID: 16421433
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
    Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
    [No Abstract]   [Full Text] [Related]  

  • 18. Leucovorin-induced hypersensitivity reaction.
    Damaske A; Ma N; Williams R
    J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.
    Saif MW; Merritt J; Robbins J; Stewart J; Schupp J
    Clin Colorectal Cancer; 2006 Sep; 6(3):229-34. PubMed ID: 17026795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.